These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Coexpression of C-erbb2 and int-2 oncogenes in invasive breast-cancer.
    Author: Elgendy S, Tahin Q, Elmerzabani M, Elaaser A, Barnabas N, Russo J.
    Journal: Int J Oncol; 1995 May; 6(5):977-84. PubMed ID: 21556627.
    Abstract:
    Invasive breast carcinomas of 19 premenopausal and 49 postmenopausal women were studied by Southern blot analysis for detection of c-erbB2 and int-2 oncogenes, and quantitation of c-erbB2 protein, p185 by ELISA. The data were correlated with the histological grade of the tumor and the patient's clinical status. Seventeen tumors (25.0%) showed genomic alteration in one or both oncogenes. c-erbB2 and int-2 amplification were expressed by 10 (14.7%) and 7 (10.2%) of the tumors respectively. c-erbB2 overexpression was found in 15 out of 68 tumors (22.1%). All tumors exhibiting amplification of c-erbB2 also showed overexpression of p185 protein, however 5 out of 15 tumors (33.3%) showing c-erbB2 overexpression did not show amplification. Rearrangement of c-erbB2 and int-2 oncogenes was observed in 4 out of 68 tumors (5.9%) and 2 of these tumors presented rearrangement of both oncogenes. A significant positive correlation was found between c-erbB2 amplification and p185 protein overexpression, and c-erbB2 and int-2 amplification. Oncogene alterations were more frequently detected in tumors with high histological grade, but no correlation was found with patient's age, menopausal or lymph node status.
    [Abstract] [Full Text] [Related] [New Search]